{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:21:41Z","timestamp":1789896101868,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.metabol.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T19:00:11Z","timestamp":1562612411000},"page":"45-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["TGR5 agonist ameliorates insulin resistance in skeletal muscles and improves glucose homeostasis in diabetic mice"],"prefix":"10.1016","volume":"99","author":[{"given":"Suling","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangliang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.07.003_bb0005","first-page":"714","article-title":"Takao Nakamura, Yoshitaka Tamai, Hiromasa Okada, Eiji Sugiyama, Tatsuji Nakamura, Hiraku Itadani, and Kenichi Tanaka*. Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Takaharu Maruyama","year":"2002","journal-title":"BBRC"},{"key":"10.1016\/j.metabol.2019.07.003_bb0010","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0015","first-page":"1319","article-title":"Bile acid receptors in the biliary tree: TGR5 in physiology and disease","volume":"2018","author":"Deutschmann","year":"1864","journal-title":"BBA-Mol Basis Dis"},{"key":"10.1016\/j.metabol.2019.07.003_bb0020","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1021\/jm501052c","article-title":"G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype","volume":"57","author":"Hogenauer","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2019.07.003_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2019.07.003_bb0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.2011.01561.x","article-title":"Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion","volume":"165","author":"Parker","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0040","first-page":"1","article-title":"TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity","volume":"7","author":"Zambad","year":"2013","journal-title":"Diabetes Metab. Syndr. Obesity Targets Ther."},{"key":"10.1016\/j.metabol.2019.07.003_bb0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1152\/ajpgi.00300.2018","article-title":"Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice","volume":"316","author":"Finn","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","article-title":"Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1","volume":"329","author":"Katsuma","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2019.07.003_bb0055","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.bmcl.2018.04.011","article-title":"Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes","volume":"28","author":"Agarwal","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.metabol.2019.07.003_bb0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2337\/db17-0607","article-title":"Mechanisms to elevate endogenous GLP-1 beyond injectable GLP-1 analogs and metabolic surgery","volume":"67","author":"Briere","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2019.07.003_bb0065","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/ijo.2013.230","article-title":"Enhancement of brown fat thermogenesis using chenodeoxycholic acid in mice","volume":"38","author":"Teodoro","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2019.07.003_bb0070","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/EJE-16-0488","article-title":"MECHANISMS IN ENDOCRINOLOGY skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?","volume":"176","author":"Brons","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI88880","article-title":"Skeletal muscle inflammation and insulin resistance in obesity","volume":"127","author":"Wu","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.metabol.2019.07.003_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-800101-1.00005-3","article-title":"Enhanced skeletal muscle for effective glucose homeostasis","volume":"121","author":"Yang","year":"2014","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.metabol.2019.07.003_bb0085","doi-asserted-by":"crossref","first-page":"T61","DOI":"10.1530\/JOE-13-0397","article-title":"Fatty acid metabolism, energy expenditure and insulin resistance in muscle","volume":"220","author":"Turner","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0090","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2019.07.003_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1586\/17512433.2016.1121808","article-title":"Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review","volume":"9","author":"Ostergaard","year":"2016","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.metabol.2019.07.003_bb0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","article-title":"The bile acid chenodeoxycholic acid increases human Brown adipose tissue activity","volume":"22","author":"Broeders","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2019.07.003_bb0105","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1074\/jbc.RA118.002733","article-title":"The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice","volume":"293","author":"Sasaki","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejmech.2013.07.050","article-title":"Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold","volume":"69","author":"Zhu","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.05.031","article-title":"4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists","volume":"82","author":"Zou","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0120","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/aps.2016.27","article-title":"OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition","volume":"37","author":"Ma","year":"2016","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.metabol.2019.07.003_bb0125","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm500829b","article-title":"Discovery of intestinal targeted TGR5 agonists for the treatment of type 2 diabetes","volume":"58","author":"Duan","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0130","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1021\/jm301071h","article-title":"Design, synthesis, and antidiabetic activity of 4-phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists","volume":"55","author":"Duan","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0135","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2337\/diab.37.9.1163","article-title":"Diet-induced type II diabetes in C57BL\/6J mice","volume":"37","author":"Surwit","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2019.07.003_bb0140","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1210\/en.2004-0219","article-title":"Genetic background (C57BL\/6J versus FVB\/N) strongly influences the severity of diabetes and insulin resistance in ob\/ob mice","volume":"145","author":"Haluzik","year":"2004","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2019.07.003_bb0145","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00125-011-2366-3","article-title":"Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob\/ob mice","volume":"55","author":"Huang","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2019.07.003_bb0150","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2337\/db14-0508","article-title":"Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation","volume":"64","author":"Pirkmajer","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2019.07.003_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085547","article-title":"Effects of inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate induced insulin resistance in L6 myotubes","volume":"8","author":"Miklosz","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.metabol.2019.07.003_bb0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/dom.12636","article-title":"Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?","volume":"18","author":"Hodge","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2019.07.003_bb0165","doi-asserted-by":"crossref","first-page":"S135-S","DOI":"10.1016\/S0016-5085(17)30783-7","article-title":"Gpbar1 (Tgr5) ligation protects against colitis development by regulating leukocyte traffinking and promoting a Il-10 dependent shift in the M1\/M2 phenotype","volume":"152","author":"Biagioli","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2019.07.003_bb0170","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bmc.2015.01.048","article-title":"Stereoselective synthesis, biological evaluation, and modeling of novel bile acid-derived G-protein coupled Bile acid receptor 1 (GP-BAR1, TGR5) agonists","volume":"23","author":"Yu","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0175","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm901390p","article-title":"Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity","volume":"52","author":"Pellicciari","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/mol.110.064501","article-title":"Functional characterization of the semisynthetic bile acid derivative INT-767, a dual Farnesoid X receptor and TGR5 agonist","volume":"78","author":"Rizzo","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0185","doi-asserted-by":"crossref","unstructured":"Potthoff MJ, Potts A, He TT, Duarte JAG, Taussig R, Mangelsdorf DJ, et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am. J. Phys. Gastrointest. Liver 2013;304:G371-G80.","DOI":"10.1152\/ajpgi.00400.2012"},{"key":"10.1016\/j.metabol.2019.07.003_bb0190","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2011.06.055","article-title":"Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet","volume":"410","author":"Ono","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2019.07.003_bb0195","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2019.07.003_bb0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2008.04.018","article-title":"Tomoko Asakawa, Osamu Kataoka, Hiroyuki Odaka. Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob\/ob mice","volume":"588","author":"Yusuke Moritoh","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cmet.2009.08.005","article-title":"Bile acids have the gall to function as hormones","volume":"10","author":"Vallim","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2019.07.003_bb0210","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","article-title":"Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells","volume":"33","author":"Kida","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0215","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1172\/JCI76289","article-title":"TGR5 reduces macrophage migration through mTOR-induced C\/EBPbeta differential translation","volume":"124","author":"Perino","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.07.003_bb0220","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jcp.25742","article-title":"TUDCA: an agonist of the bile acid receptor GPBAR1\/TGR5 with anti-inflammatory effects in microglial cells","volume":"232","author":"Yanguas-Casas","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0225","first-page":"1811","article-title":"The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells","volume":"33","author":"GdP","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.metabol.2019.07.003_bb0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.metabol.2018.12.009","article-title":"Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans","volume":"93","author":"van Nierop","year":"2019","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.metabol.2019.07.003_bb0235","doi-asserted-by":"crossref","unstructured":"Dong ZH, Chai WD, Wang WH, Zhao LN, Fu Z, Cao WH, et al. Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment. Am. J. Physiol. Endocrinol. Metab. 2013;304:E222-E8.","DOI":"10.1152\/ajpendo.00473.2012"},{"key":"10.1016\/j.metabol.2019.07.003_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yjmcc.2010.10.010","article-title":"PKA and Epac synergistically inhibit smooth muscle cell proliferation","volume":"50","author":"Hewer","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0245","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s13105-017-0594-9","article-title":"Preventive effect of oleate on palmitate-induced insulin resistance in skeletal muscle and its mechanism of action","volume":"73","author":"Alkhateeb","year":"2017","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.metabol.2019.07.003_bb0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/me.2015-1201","article-title":"Sustained betaAR stimulation mediates cardiac insulin resistance in a PKA-dependent manner","volume":"30","author":"Mangmool","year":"2016","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0255","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00210-013-0860-5","article-title":"\u03b22-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling","volume":"386","author":"Ngala","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mce.2016.07.018","article-title":"Thyroid-stimulating hormone improves insulin sensitivity in skeletal muscle cells via cAMP\/PKA\/CREB pathway-dependent upregulation of insulin receptor substrate-1 expression","volume":"436","author":"Moon","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2019.07.003_bb0265","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1016\/S0021-9258(19)34116-X","volume":"265","author":"Chijiwa","year":"1990","journal-title":"J Biol Chem"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519301362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519301362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:20:28Z","timestamp":1758428428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519301362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":53,"alternative-id":["S0026049519301362"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.07.003","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGR5 agonist ameliorates insulin resistance in skeletal muscles and improves glucose homeostasis in diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}